In lung cancer, IL-6/STAT3-inducible USP24 stabilizes PD-1 protein by deubiquitinating K48-linked ubiquitin chains; USP24 inhibition suppresses T-cell exhaustion and restores immunotherapy responsiveness, implicating IP-regulated deubiquitination in immune escape (83). Here, USP24 is linked to lung cancer.